Related Experiment Video
Updated: Jul 9, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Cardiogenic shock: basics and clinical considerations.
Ramesh M Gowda1, John T Fox, Ijaz A Khan
1Division of Cardiology, Beth Israel Medical Center, New York, New York, USA.
Cardiogenic shock, a severe heart failure complication, causes organ hypoperfusion. While treatments like early coronary intervention improve outcomes, inflammatory pathways and complement system activation are key to its pathogenesis and potential therapeutic targets.
Area of Science:
- Cardiology
- Critical Care Medicine
- Immunology
Background:
- Cardiogenic shock is a life-threatening condition of hypoperfusion due to heart failure.
- It lacks precise hemodynamic definitions but involves low blood pressure and organ dysfunction.
- Acute myocardial infarction is the leading cause, carrying high mortality.
Purpose of the Study:
- To review the historical perspective, epidemiology, etiology, pathophysiology, risk predictors, and management of cardiogenic shock.
- To highlight the role of inflammatory responses and complement system in cardiogenic shock.
- To discuss emerging therapeutic strategies targeting these pathways.
Main Methods:
- This is a review article synthesizing existing literature.
- It covers historical data, epidemiological studies, etiological factors, and pathophysiological mechanisms.
- Management strategies, including traditional and novel approaches, are discussed.
Main Results:
- Acute myocardial infarction is the most common cause of cardiogenic shock.
- Intra-aortic balloon counterpulsation and early coronary interventions have improved patient outcomes.
- Inflammatory pathways, including nitric oxide synthase and complement system activation, are crucial in pathogenesis.
Conclusions:
- Cardiogenic shock remains a critical condition with significant mortality.
- Inflammatory response and complement system activation are important in its development and progression.
- Inhibitors of nitric oxide synthase and C5 complement are under investigation as potential treatments.
Related Concept Videos
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Cardiopulmonary Resuscitation IV: Pharmacological Management
Introduction Cardiac Emergencies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Heart Failure I: Introduction
Pathophysiology of Heart Failure
